Inventing what’s miss^ng

So you can get back to what matters.

Since 2020, we have been making innovative treatments available to patients with no therapeutic option.
From the cornea to life’s very first breaths.

2020

Founded in Clermont-Ferrand

15,000+

Patients treated

Countries covered

Who we are

We were born of a refusal: to leave patients without a solution

KÔL combines recognised expertise in early and compassionate access to treatments for rare diseases with long-standing expertise in ophthalmology.

Built with the energy of a start-up, KÔL combines the agility of a biotech with the rigour of a pharmaceutical laboratory.

Where needs remain unmet

Cornea and retina: corneal transplantation, neovascularisation, severe inflammatory syndromes, AMD research, genetic diseases.

Heart and lung diseases.

Our commitment

Late diagnoses, limited knowledge, few treatment options. We make innovation accessible when there is no alternative.

7,000+

rare diseases identified

30M

patients in Europe

70%

begin in childhood

95%

have no curative treatment